Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis and alcohol use disorders: In-hospital mortality, extended hospital stays, and overexpenditures.
NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.
Electroconvulsive Therapy in Multiple Sclerosis.
Grey matter atrophy is associated with disability increase in natalizumab-treated patients.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.
Acute disseminated encephalomyelitis in a case of autoimmune haemolytic anaemia: a rare association.
TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.
Rasch analysis of the Fatigue Severity Scale in Italian subjects with multiple sclerosis.
The Effects of Aquatic Exercise on Gait and Strength in Individuals with Multiple Sclerosis: 1426 Board #79 June 2, 8: 00 AM - 9: 30 AM.
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures.
Treatment with NAD(+) inhibited experimental autoimmune encephalomyelitis by activating AMPK/SIRT1 signaling pathway and modulating Th1/Th17 immune responses in mice.
Optic neuropathy associated with systemic sarcoidosis.
Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
The hypothetical roles of arsenic in multiple sclerosis by induction of inflammation and aggregation of tau protein: A commentary.
Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2.
Pure alexia in a patient with multiple sclerosis.
Vitamin D₃ and Monomethyl Fumarate Enhance Natural Killer Cell Lysis of Dendritic Cells and Ameliorate the Clinical Score in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
Defects in the COG complex and COG-related trafficking regulators affect neuronal Golgi function.
Differential Expression of Glucocorticoid Receptor Noncoding RNA Repressor Gas5 in Autoimmune and Inflammatory Diseases.
The Added Value of Family Material in the Discovery of Multiple Sclerosis Genes.
Postarrest stalling rather than crawling favors CD8(+) over CD4(+) T-cell migration across the blood-brain barrier under flow in vitro.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial.
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients.
Pages
« first
‹ previous
…
826
827
828
829
830
831
832
833
834
…
next ›
last »